Filing Details
Q32 Bio Inc. (NASDAQ:QTTB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 05, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:QTTB
Q32 Bio Inc. (QTTB) Files Quarterly Report for Q0
Filing Details Q32 Bio Inc. (NASDAQ:QTTB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 05, 2026. The Healthcare company reported Q0…
Market Context
Q32 Bio Inc.'s stock currently trades at $16.49 with a market capitalization of $39.2M.
The 10-Q provides Q32 Bio Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Q32 Bio Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View QTTB Stock Page
Frequently Asked Questions
Where can I read QTTB's SEC filings?
Browse all filings on our QTTB SEC filings page.
What types of SEC filings does Q32 Bio Inc. file?
Public companies like Q32 Bio Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.